0 0
Spread the Message
              
Read Time:40 Second
31 March 2022  WHO News release
After reviewing a number of proposals from India, WHO’s Product Development for Vaccines Advisory Committee (PDVAC) today selected the company BiologicalE (Bio E) as a recipient of mRNA technology from the WHO technology transfer hub.
Bio E already manufactures a number of critical vaccines, including Corbevax, a second-generation vaccine for COVID-19.

WHO and partners will work with the Indian government and Bio E to develop a roadmap and put in place the necessary training and support so that the company can start producing mRNA vaccines as soon as possible.

Primarily set up to address the COVID-19 emergency, the hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer.

About Post Author

Admin

[email protected]
https://healthandfamiliy.in
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %